$8.20
0[0.00%]
At close: Apr 24
$8.20
0[0.00%]
After Hours: 7:49PM EDT
Outlook Therapeutics
(NASDAQ:OTLK)Outlook Therapeutics Stock (NASDAQ:OTLK), Earnings Estimates, EPS, and Revenue
Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 14
EPS
$-0.800
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | AM | OTLK | Q2 | -$0.60 | — | — | — | $0.00 | — | — | — | Get Alert |
| 02/14/2024 | AM | OTLK | Q1 | -$1.60 | — | -$0.80 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/22/2023 | PM | OTLK | Q4 | -$1.20 | — | -$1.00 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2023 | AM | OTLK | Q3 | -$1.60 | -$1.00 | -$1.60 | -60.00% | $0.00 | — | $0.00 | — | Get Alert |
| 05/15/2023 | AM | OTLK | Q2 | -$1.80 | -$1.20 | -$0.60 | 50.00% | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2023 | AM | OTLK | Q1 | -$1.40 | -$0.80 | -$1.60 | -100.00% | $0.00 | — | $0.00 | — | Get Alert |
| 12/29/2022 | AM | OTLK | Q4 | -$1.60 | -$1.40 | -$1.20 | 14.29% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2022 | AM | OTLK | Q3 | -$1.40 | — | -$1.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/13/2022 | AM | OTLK | Q2 | -$1.80 | — | -$1.80 | — | $0.00 | — | $0.00 | — | Get Alert |
| 02/14/2022 | AM | OTLK | Q1 | -$2.40 | -$1.20 | -$1.40 | -16.67% | $0.00 | — | $0.00 | — | Get Alert |
| 12/22/2021 | AM | OTLK | Q4 | -$0.60 | -$1.20 | -$1.60 | -33.33% | $0.00 | $300.00K | $0.00 | -100.00% | Get Alert |
| 08/13/2021 | AM | OTLK | Q3 | -$0.60 | -$1.40 | -$1.40 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | Get Alert |
| 05/14/2021 | AM | OTLK | Q2 | -$2.60 | -$1.80 | -$1.80 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | Get Alert |
| 02/16/2021 | AM | OTLK | Q1 | -$12.40 | — | -$2.40 | — | $0.00 | — | $0.00 | — | Get Alert |
| 12/23/2020 | AM | OTLK | Q4 | -$39.60 | — | -$0.60 | — | $5.85M | — | $0.00 | — | Get Alert |
| 08/14/2020 | AM | OTLK | Q3 | -$4.80 | — | -$2.20 | — | $584.00K | — | $0.00 | — | Get Alert |
| 05/15/2020 | AM | OTLK | Q2 | -$11.60 | — | -$2.60 | — | $641.00K | — | $0.00 | — | Get Alert |
| 02/14/2020 | AM | OTLK | Q1 | -$20.00 | — | -$12.40 | — | — | — | $0.00 | — | Get Alert |
| 12/19/2019 | AM | OTLK | Q4 | — | — | $1.00 | — | — | — | $5.85M | — | Get Alert |
FAQ
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics (OTLK) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on February 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?
The Actual EPS was $-0.80, which missed the estimate of $0.00.
What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.